Managers

Benjamin Péant

Benjamin Péant

PhD

AS

Amélie St-Georges-Robillard

PhD

Microfluidic devices (also called lab-on-a-chip devices) offer excellent spatial-temporal control over biological samples and their microenvironments.   

The devices preserve the viability and architecture of tissue samples under appropriate culture conditions. In oncology, the microfluidics approach can be used to observe the effects of chemotherapy and radiation therapy treatments on solid tumour and biopsy samples. 

 

Our team

Benjamin Péant

Benjamin Péant

PhD

Co-Manager

AS

Amélie St-Georges-Robillard

PhD

Co-Manager

JK

Jennifer Kendall-Dupont

MSc

Specialist

Anne-Marie MES-MASSON

Anne-Marie Mes-Masson

PhD, FCAHS, FRSC

Scientific Co-Advisor

TG

Thomas Gervais

PhD, Eng

Scientific Co-Advisor

In figures

  • >than 50,000 microtumours produced in 2 years

    > than 1,500 microfluidic devices, each loaded with 32 microtumours

    about 40 people trained in 2 years